Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000205791 | SCV000260128 | likely benign | Neurofibromatosis, type 1 | 2024-12-16 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000219959 | SCV000272950 | likely benign | Hereditary cancer-predisposing syndrome | 2014-11-25 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV000603656 | SCV000724573 | likely benign | not specified | 2017-11-08 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000603656 | SCV002014991 | likely benign | not specified | 2021-10-20 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV000603656 | SCV002065340 | likely benign | not specified | 2021-06-07 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV000219959 | SCV002528107 | likely benign | Hereditary cancer-predisposing syndrome | 2022-02-19 | criteria provided, single submitter | curation | |
Genome- |
RCV000205791 | SCV002561298 | likely benign | Neurofibromatosis, type 1 | 2022-03-15 | criteria provided, single submitter | clinical testing |